Sparking criticism and raising concerns, British-Swedish multinational pharmaceutical firm AstraZeneca has for the first time acknowledged in court documents in the UK that its Covid-19 vaccine, which is known as Covishield in India, has the potential to cause Thrombosis with Thrombocytopenia